Stocks to Trade
Navidea Biopharmaceuticals, Inc. (NAVB) Stock Surged 25.28% Pre-Market, Here’s Why
Navidea Biopharmaceuticals, Inc. (NAVB) stock soared 25.58% in the pre-market trading session at the price of $1.11 following the regulatory approval of Lymphoaim in India. NAVB is a biopharmaceutical firm centered on the production of innovative immuno-diagnostic agents. The company is devising numerous precision-targeted
